9 studies found for:    "HTLV-1 associated myelopathy/tropical spastic paraparesis"
Show Display Options
Rank Status Study
1 Recruiting Raltegravir for HAM/TSP
Conditions: HAM/TSP;   HTLV-1
Intervention: Drug: Raltegravir
2 Completed MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Condition: Tropical Spastic Paraparesis
Intervention:
3 Unknown  Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Tamibarotene
4 Completed Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV I Associated Myelopathy
Intervention: Drug: ciclosporin
5 Suspended Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Condition: HTLV-1
Intervention: Drug: Hu MiK-Beta-1
6 Terminated Safety and Efficiency Study of Valproic Acid In HAM/TSP
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Valproic Acid
7 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
8 Terminated The HAM Infliximab Study
Condition: HTLV-I-associated Myelopathy
Intervention: Drug: Infliximab
9 Completed Zidovudine Plus Lamivudine in HTLV-I-Associated Myelopathy: a Randomised Trial
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Zidovudine/lamivudine

Indicates status has not been verified in more than two years